Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jacob Rabinson

Showing results (21-30 of 28) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 28 results.
Fertility and Sterility|May 3, 2006
Müllerian anomalies, hearing loss, and connexin 26 mutationsJacob Rabinson, Raoul Orvieto, Amnon Shapira, et al.
Fertility and Sterility|October 15, 2008
Follitropin-alpha (Gonal-F) versus follitropin-beta (Puregon) in controlled ovarian hyperstimulation for in vitro fertilization: is there any difference?Raoul Orvieto, Ravit Nahum, Jacob Rabinson, et al.
Fertility and Sterility|August 5, 2008
Ultrashort flare GnRH agonist combined with flexible multidose GnRH antagonist for patients with repeated IVF failures and poor embryo qualityRaoul Orvieto, Ravit Nahum, Jacob Rabinson, et al.
Reproductive Biomedicine Online|February 5, 2009
HMG improves IVF outcome in patients with high basal FSH/LH ratio: a preliminary studyRaoul Orvieto, Roy Homburg, Simion Meltcer, et al.
Reproductive Biomedicine Online|March 21, 2009
Ovarian stimulation in polycystic ovary syndrome patients: the role of body mass indexRaoul Orvieto, Ravit Nahum, Simion Meltcer, et al.
Gynecological Endocrinology : the Official Journal of the International Society of Gynecological Endocrinology|April 25, 2007
The influence of estradiol/follicle and estradiol/oocyte ratios on the outcome of controlled ovarian stimulation for in vitro fertilizationRaoul Orvieto, Efraim Zohav, Shimon Scharf, et al.
Gynecological Endocrinology : the Official Journal of the International Society of Gynecological Endocrinology|September 14, 2007
Controlled ovarian hyperstimulation using multi-dose gonadotropin-releasing hormone (GnRH) antagonist results in less systemic inflammation than the GnRH-agonist long protocolRaoul Orvieto, Michael Volodarsky, Eduard Hod, et al.
Frontiers in Reproductive Health|January 23, 2024
Is there any truth in the myth that IVF treatments involve weight gain?Bozhena Saar-Ryss, Michael Shilo, Michael Friger, et al.
Pageof 3

Showing results (21-30 of 28) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 28 results.
Fertility and Sterility|May 3, 2006
Müllerian anomalies, hearing loss, and connexin 26 mutationsJacob Rabinson, Raoul Orvieto, Amnon Shapira, et al.
Fertility and Sterility|October 15, 2008
Follitropin-alpha (Gonal-F) versus follitropin-beta (Puregon) in controlled ovarian hyperstimulation for in vitro fertilization: is there any difference?Raoul Orvieto, Ravit Nahum, Jacob Rabinson, et al.
Fertility and Sterility|August 5, 2008
Ultrashort flare GnRH agonist combined with flexible multidose GnRH antagonist for patients with repeated IVF failures and poor embryo qualityRaoul Orvieto, Ravit Nahum, Jacob Rabinson, et al.
Reproductive Biomedicine Online|February 5, 2009
HMG improves IVF outcome in patients with high basal FSH/LH ratio: a preliminary studyRaoul Orvieto, Roy Homburg, Simion Meltcer, et al.
Reproductive Biomedicine Online|March 21, 2009
Ovarian stimulation in polycystic ovary syndrome patients: the role of body mass indexRaoul Orvieto, Ravit Nahum, Simion Meltcer, et al.
Gynecological Endocrinology : the Official Journal of the International Society of Gynecological Endocrinology|April 25, 2007
The influence of estradiol/follicle and estradiol/oocyte ratios on the outcome of controlled ovarian stimulation for in vitro fertilizationRaoul Orvieto, Efraim Zohav, Shimon Scharf, et al.
Gynecological Endocrinology : the Official Journal of the International Society of Gynecological Endocrinology|September 14, 2007
Controlled ovarian hyperstimulation using multi-dose gonadotropin-releasing hormone (GnRH) antagonist results in less systemic inflammation than the GnRH-agonist long protocolRaoul Orvieto, Michael Volodarsky, Eduard Hod, et al.
Frontiers in Reproductive Health|January 23, 2024
Is there any truth in the myth that IVF treatments involve weight gain?Bozhena Saar-Ryss, Michael Shilo, Michael Friger, et al.
Pageof 3